Relation of Preprocedural Statin Therapy to In-Hospital Procedural Complications Following Percutaneous Coronary Interventions in Patients With Hyperlipidemia

Mortality Differences Between Men and Women After Percutaneous Coronary Interventions: A 25-Year, Single-Center Experience

“…The long-term predictors associated with lower mortality included hyperlipidemia and presence of thrombus. We have shown previously that hyperlipidemia was associated with decreased in-hospital mortality and increased postprocedural cardiac biomarker levels (19).…”

“…History of CHF 330 (15) 537 (9) 572 (17) 940 (12) . 16 Current smoker 422 (19) 1,281 (23) 589 181,489 (20) . 3146 3338 (10) 968 (13) .06…”

Mortality Differences Between Men and Women After Percutaneous Coronary Interventions

“…Since 1979, data from patients undergoing PCI at Mayo Clinic have been recorded in a prospective registry. For the present study, we considered 19,238 consecutive, unique patients undergoing PCI at Mayo Clinic Rochester. We considered the first PCI performed at Mayo Clinic for each patient; thus, patients with prior PCI performed elsewhere were included, and repeat procedures performed at Mayo Clinic were excluded.…”

“…We have shown previously that hyperlipidemia was associated with decreased in-hospital mortality and increased postprocedural cardiac biomarker levels (19). The decreases in adverse outcomes were limited to patients taking statin drugs at the time of PCI.…”

Impact of increased admission lipid levels on periprocedural myocardial injury following an elective percutaneous coronary intervention

“…Moreover, a previously reported guideline reported a history of hyperlipidemia as a preventive clinical factor against PMI [10]. However, it was reported that the observed benefit in hyperlipidemic patients was because of preprocedural statin therapy rather than hyperlipidemia itself [11]. In contrast, Mandadi et al [12] reported that PMI is correlated positively with history of hypercholesterolemia in patients either treated or untreated with statins.…”